SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2360)12/20/2000 8:42:32 PM
From: thebeach  Read Replies (2) | Respond to of 52153
 
Here is a few great reasons to buy some Procyon Biopharma Inc(PBP-T)
Here's why you should buy this stock. This is a no brainer!

From the latest financial statements (Nov. 24th)

CF = $17,402,594
DEBT = $959,415
BOOK VALUE = $0.55 / share (P/BOOK = 1.45 @ price of $0.80)
CF/SH = $0.47

Add to this what we already know i.e. that PBP is a good solid company with
great products and there you have it: a no brainer: BUY!! This is an
easy double short-term and a grand slam long-term...

Long on PBP!
Thanks to someone else from another thread.



To: Jibacoa who wrote (2360)12/27/2000 6:07:56 PM
From: Jibacoa  Read Replies (2) | Respond to of 52153
 
SQNM:

It seems it is not going to drop to single digits. Is making a base at 13 1/2 and if it can close above yesterday's H of 15 1/4 it should test the intra-day gap of Dec.19 at 16. The down-trend coming from the Oct.2 H at 45 1/2 will not be broken until it can close above 21 5/8, which was the Dec.11 H

Sorry. I was making a note for myself. I think I have the right stock, but the wrong subject (TA )for this thread.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News